Drug Profile
BS TA B17
Alternative Names: BA-TA-B17Latest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator Hangzhou Bensheng Pharmaceutical
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Lung cancer
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for preclinical development in Lung-cancer in China